[1]林婧,吴丹*.妊娠期人乳头瘤病毒感染的筛查与处理[J].中国计划生育和妇产科,2019,(2):15-18.
点击复制

妊娠期人乳头瘤病毒感染的筛查与处理
分享到:

《中国计划生育和妇产科》[ISSN:1674-4020/CN:51-1708/R]

卷:
期数:
2019年2期
页码:
15-18
栏目:
综述
出版日期:
2019-02-25

文章信息/Info

作者:
林婧吴丹*
上海交通大学医学院附属国际和平妇幼保健院宫颈科
关键词:
妊娠期人乳头状瘤病毒筛查处理
分类号:
R 711.74

参考文献/References:

[1]薛凤霞,王宝晨.中国HPV感染面临的问题与挑战 [J].国际生殖健康/计划生育杂志,2015,34(6):445-449. [2]LIU P, XU L, SUN Y, et al. The prevalence and risk of human papillomavirus infection in pregnant women [J]. Epidemiology and Infection, 2014, 142(8): 1567-1578. [3]SALCEDO M M, DAMIN A P, AGNES G, et al. Prevalence of human papillomavirus infection in pregnant versus non-pregnant women in Brazil [J]. Archives of Gynecology and Obstetrics, 2015, 292(6): 1273-1278. [4]姚守珍,刘玲,王璐璐.复发性流产孕妇早期妊娠滋养细胞中E-钙黏素的表达与HPV感染的相关性[J].中华医院感染学杂志,2014,24(12):3038-3040. [5]FIFE K H, KATZ B P, ROUSH J, et al. Cancer-associated human papillomavirus types are selectively increased in the cervix of women in the first trimester of pregnancy [J]. American Journal of Obstetrics and Gynecology, 1996, 174(5): 1487-1493. [6]CUNNINGHAM F C, LEVENO K J, B100M S L, et al. Williams 0bstetrics 24th ed [Z], 2014: 1291. [7]FREITAS A C, MARIZ F C, SILVA M A, et al. Human papillomavirus vertical transmission: review of current data[J]. Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America, 2013, 56(10): 1451-1456. [8]ROMBALDI R L, SERAFINI E P, MANDELLI J, et al. Perinatal transmission of human papilomavirus DNA [J]. Virology Journal, 2009, 6(1): 83. [9]ROPERTO S, BORZACCHIELLO G, ESPOSITO I, et al. Productive infection of bovine papillomavirus type 2 in the placenta of pregnant cows affected with urinary bladder tumors [J]. PLOS One, 2012, 7(3): e33569. [10]YOSHIDA K, FURUMOTO H, ABE A, et al. The possibility of vertical transmission of human papillomavirus through maternal milk [J]. Journal of Obstetrics and Gynaecology, 2011, 31(6): 503-506. [11]KOSKIMAA H M, WATERBOER T, PAWLITA M, et al. Human papillomavirus genotypes present in the oral mucosa of newborns and their concordance with maternal cervical human papillomavirus genotypes [J]. The Journal of Pediatrics, 2012, 160(5): 837-843. [12]WORKOWSKI K A. Centers for disease control and prevention sexually transmitted diseases treatment guidelines[J]. Clinical Infectious Diseases, 2015, 61(8): S759-S762. [13]YANG Rui, WANG Ying, QIAO Jie, et al. Does human papillomavirus infection do harm to in-vitro fertilization outcomes and subsequent pregnancy outcomes?[J]. Chinese Medical Journal, 2013, 126(4): 683-687. [14]LACOUR D E, TRIMBLE C. Human papillomavirus in infants: transmission, prevalence, and persistence [J]. Journal of Pediatric and Adolescent Gynecology, 2012, 25(2): 93-97. [15]PARK H, LEE S W, LEE I H, et al. Rate of vertical transmission of human papillomavirus from mothers to infants: relationship between infection rate and mode of delivery [J]. Virology Journal, 2012, 9: 80. [16]SKINNER S R, SZAREWSKI A, ROMANOWSKI B, et al. Efficacy, safety, and immunogenicity of the human papillomavirus 16/18 AS04-adjuvanted vaccine in women older than 25 years: 4-year interim follow-up of the phase 3, double-blind, randomised controlled VIVIANE study[J]. Lancet, 2014, 384(9961): 2213-2227. [17]QUINEY R E, WELLS M, LEWIS F A, et al. Laryngeal papillomatosis: correlation between severity of disease and presence of HPV 6 and 11 detected by in situ DNA hybridisation[J]. Journal of Clinical Pathology, 1989, 42(7): 694-698. [18]FREITAS A C, MARIZ F C, SILVA M A, et al. Human papillomavirus vertical transmission: review of current data[J]. Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America, 2013, 56(10): 1451-1456. [19]BOULENOUAR S, WEYN C, VAN NOPPEN M, et al. Effects of HPV-16 E5, E6 and E7 proteins on survival, adhesion, migration and invasion of trophoblastic cells[J]. Carcinogenesis, 2010, 31(3): 473-480. [20]CHEN S S, BLOCK B S, CHAN P J. Pentoxifylline attenuates HPV-16 associated necrosis in placental trophoblasts[J]. Archives of Gynecology and Obstetrics, 2015, 291(3): 647-652. [21]尹香花,石敏.妊娠期人乳头状瘤病毒感染母婴传播及预后的研究进展 [J].中国妇产科临床杂志,2015,16(3):286-288. [22]眭鸿颖,史彩霞,江宁,等.高危型HPV感染对宫颈病变组织IFN-γ、IL-10表达的影响 [J].现代生物医学进展,2016,16(13):2484-2486. [23]KWON J Y, ROMERO R, MOR G. New insights into the relationship between viral infection and pregnancy complications[J]. American Journal of Reproductive Immunology (New York, N.Y. : 1989), 2014, 71(5): 387-390. [24]GOMEZ L M, MA Y, HO C, et al. Placental infection with human papillomavirus is associated with spontaneous preterm delivery [J]. Human Reproduction (Oxford, England), 2008, 23(3): 709-715. [25]中华预防医学会妇女保健分会.子宫颈癌综合防控指南 [M].北京:人民卫生出版社,2017:51-53. [26]ORIGONI M, SALVATORE S, PERINO A, et al. Cervical intraepithelial neoplasia (CIN) in pregnancy: the state of the art[J]. European Review for Medical and Pharmacological Sciences, 2014, 18(6): 851-860. [27]STILLSON T, KNIGHT A L, ELSWICK R K. The effectiveness and safety of two cervical cytologic techniques during pregnancy[J]. The Journal of Family Practice, 1997, 45(2): 159-163. [28]CLAVEL C, MASURE M, BORY J P, et al. Human papillomavirus testing in primary screening for the detection of high-grade cervical lesions: a study of 7932 women[J]. British Journal of Cancer, 2001, 84(12): 1616-1623. [29]魏丽惠,赵昀,谢幸,等.妊娠合并子宫颈癌管理的专家共识[J].中国妇产科临床杂志,2018,19(2):190-192. [30]FADER A N, ALWARD E K, NIEDERHAUSER A, et al. Cervical dysplasia in pregnancy: a multi-institutional evaluation[J]. American Journal of Obstetrics and Gynecology, 2010, 203(2): 113.e1-113.e6. [31]DESIMONE C P, Dayme, TOVAR M M, et al. Rate of pathology from a typical glandular cell pap tests classified by the Bethesda 2001 nomenclature[J]. Obstetrics and Gynecology, 2006, 107(6): 1285-1291. [32]COPPOLILLO E F, DE RUDA VEGA H M, BRIZUELA J, et al. High-grade cervical neoplasia during pregnancy: diagnosis, management and postpartum findings[J]. Acta Obstetricia et Gynecologica Scandinavica, 2013, 92(3): 293-297. [33]PARASKEVAIDIS E, KOLIOPOULOS G, KALANTARIDOU S, et al. Management and evolution of cervical intraepithelial neoplasia during pregnancy and postpartum [J]. European Journal of Obstetrics & Gynecology and Reproductive Biology, 2002, 104(1): 67-69. [34]SIEGLER E, LAVIE O, AMIT A, et al. Should the risk of invasive cancer in pregnancy and the safety of loop electrosurgical excision procedure during the first 15 weeks change our practice?[J]. Journal of Lower Genital Tract Disease, 2017, 21(4): 299-303. [35]LIU Yi, QIU Hai-fan, TANG Yunbing, et al. Pregnancy outcome after the treatment of loop electrosurgical excision procedure or cold-knife conization for cervical intraepithelial neoplasia [J]. Gynecologic and Obstetric Investigation, 2014, 77(4): 240-244. [36]KYRGIOU M, ATHANASIOU A, PARASKEVAIDI M, et al. Adverse obstetric outcomes after local treatment for cervical preinvasive and early invasive disease according to cone depth: systematic review and meta-analysis[J]. BMJ (Clinical Research ed.), 2016, 354(11): i3633. [37]CASTANON A, LANDY R, BROCKLEHURST P, et al. Risk of preterm delivery with increasing depth of excision for cervical intraepithelial neoplasia in England: nested case-control study[J]. BMJ (Clinical Research ed.), 2014, 349(1): g6223. [38]HIMES K P, SIMHAN H N. Time from cervical conization to pregnancy and preterm birth[J]. Obstetrics and Gynecology, 2007, 109(2 Pt 1): 314-319.

相似文献/References:

[1]吴池华,刘锦平.妊娠哺乳期乳腺癌的临床问题[J].中国计划生育和妇产科,2009,(05):0.
 WU Chi-hua,LIU Jin-ping The department of breast surgery,The academy of science · Sichuan provincal peoples hospital.[J].Chinese Journal of Family Planning & Gynecotokology,2009,(2):0.
[2]陶凤喜,王海新.HPV感染与宫颈病变的关系分析[J].中国计划生育和妇产科,2010,(05):0.
 TAO Feng-xi,WANG Hai-xin.[J].Chinese Journal of Family Planning & Gynecotokology,2010,(2):0.
[3]范余娟,蒙亚晴,罗雪慧,等.女性外阴尖锐湿疣HPV感染类型及其与临床复发关系研究[J].中国计划生育和妇产科,2011,(01):0.
 FAN Yu-Juan,MENG Ya-Qing,LUO Xue-hui,et al.[J].Chinese Journal of Family Planning & Gynecotokology,2011,(2):0.
[4]石一复,李娟清.人乳头状瘤病毒及其预防性疫苗的现况[J].中国计划生育和妇产科,2011,(02):0.
[5]李婷婷,史惠蓉.宫颈新柏氏液基细胞学检查假阴性结果分析[J].中国计划生育和妇产科,2011,(02):0.
 LI Ting-ting,SHI Hui-rong.[J].Chinese Journal of Family Planning & Gynecotokology,2011,(2):0.
[6]范余娟,蒙亚晴.外阴癌病因学研究进展[J].中国计划生育和妇产科,2011,(04):0.
 FAN Yu-juan,MENG Ya-qing.[J].Chinese Journal of Family Planning & Gynecotokology,2011,(2):0.
[7]李东红,王宝玲,戴瑜平,等.局部应用5-氟尿嘧啶对子宫颈上皮内瘤变锥切后人乳头状瘤病毒阳性者病变转归的影响[J].中国计划生育和妇产科,2012,(02):0.
 LI Dong-hong,WANG Bao-ling,DAI Yu-ping,et al.[J].Chinese Journal of Family Planning & Gynecotokology,2012,(2):0.
[8]夏晓梦,方小玲.妊娠期宫颈细胞学与阴道镜检查的特征与处理[J].中国计划生育和妇产科,2013,(01):0.
 XIA Xiao-meng,FANG Xiao-ling*.[J].Chinese Journal of Family Planning & Gynecotokology,2013,(2):0.
[9]陈志龙,史惠蓉.人乳头状瘤病毒L1蛋白在宫颈病变中的表达及其意义[J].中国计划生育和妇产科,2013,(01):0.
 CHEN Zhi-long,SHI Hui-rong*.[J].Chinese Journal of Family Planning & Gynecotokology,2013,(2):0.
[10]李光辉,孔丽君,张为远,等.子痫前期的脂代谢[J].中国计划生育和妇产科,2014,(01):0.
 LI Guang-hui,KONG Li-jun,ZHANG Wei-yuan,et al.[J].Chinese Journal of Family Planning & Gynecotokology,2014,(2):0.

更新日期/Last Update: 2019-02-25